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Background: Endothelial progenitor cells (EPCs) are increasingly becoming a major focus of regenerative medicine
research and practice. The present study was undertaken to establish an appropriate procedure for isolation and
characterization of EPCs from Rhesus monkeys for regenerative medicine research.
Result: Selective CD34+ and nonselective mononuclear EPCs were isolated from bone marrow and cultured under
varying conditions. The results showed that nonselective mononuclear EPCs were a better choice for high yield of
the target cells. The cells grew in M 200 better than in EGM-2, and supplementation with fetal bovine serum
promoted cell proliferation; but serum level at 7.5% was better than at 10%. In addition, surface coating of the
culture dishes with human fibronectin significantly improved the proliferation and ontogeny of the isolated EPCs.
Immunocytochemistry including detection of markers CD34, CD133 and CD31 and double-staining for Ac-LDL and
lectin verified the purity of the cultured mononuclear EPCs.
Conclusion: By a thorough analysis, we established a practical procedure for isolation and propagation of EPCs
from Rhesus monkeys. This procedure would help using these valuable cells for regenerative medicine research.
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Endothelial progenitor cells (EPCs) are increasingly be-
coming a major focus of regenerative medicine research
and practice. These cells are enriched in the mononuclear
cell fraction of peripheral blood but have also been iso-
lated from bone marrow, the vessel wall, and a number of
other organs and tissues [1-3]. Both experimental [4-7]
and human clinical trials of EPC-based therapies [8-10]
have generated encouraging results that underscored the
significance of this cell type in cardiovascular medicine; a
role for EPCs in the modulation of angiogenesis has been
recognized [1-3]. However, there are a number of elusive
issues in a comprehensive understanding of the usefulness
of EPCs. For instance, it is unknown for the precise on-
togeny and lineage of these cells, the true extent to which
EPCs participate in neovascularization and vascular repair,
and the efficacy of EPC-based regenerative therapies
[11-13].
The encouraging data for the clinically potential of
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reproduction in any medium, provided the orclinical use have prompted an explosion of interest in
experimental and clinical understanding of EPCs. Stud-
ies have focused on the role of EPCs in postnatal vascu-
logenesis in human health and disease [14-18]. In this
context, purification and characterization of EPCs from
rodent animal models have generated exciting data
[16,19-21]. However, there are significant limitations in
these rodent studies, and the most noticeable restriction
is the uncertainty of the extrapolation of the experimen-
tal data to humans due to remarkable variations in many
aspects of physiology and pathogenesis between rodents
and humans [22].
Non-human primate models of human disease and
pathogenesis have become increasingly demanded experi-
mental models for cardiovascular medicine. This is due
largely to the emphasis of translational medicine research
and the close similarity between non-human primates and
humans in many aspects of cardiovascular physiology and
pathology [23,24]. With regard to the study of EPCs in
cardiovascular medicine, the monkey model would pro-
vide an excellent assessment for the development of their
potential for clinical application. It is thus of significant
experimental and clinical interest to develop a procedure. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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from monkeys for the purpose stated above.
In the present study, we carefully analyzed the effects of
different procedures including purification, culturing con-
ditions, culture medium compositions, and selection of
culture glassware on EPCs isolated from Rhesus monkeys.
An optimized procedure was developed to achieve a high
yield and stable culture of the EPCs from monkeys. This
procedure would greatly enhance the efficacy and reliabil-
ity of the cultured EPCs isolated from monkeys for the
studies of their growth and differentiation, as well as their
lineage and participation in neovascularization.
Results
Effects of isolation procedures on the yield and
characterization of EPCs isolated from Rhesus monkeys
Mononuclear EPCs isolated from bone marrow by gradi-
ent centrifugation were either directly cultured or sub-
jected to CD34-affinity column for further purification.
The data presented in Figure 1A show the difference inFigure 1 The morphology of EPCs isolated from Rhesus monkeys. A.
were cultured in M 200, observed on day 6 (6D) or day 9 (9D) after culturin
unselected mononuclear cells were cerioid shape on day 6, formed cobble
with the loss of stereognosis after first passage. Bar =200 μm. B. Unselected
observed on day 5 (5D), day 8 (8D) after culturing and day 1 after the first
but cells in EGM-2 had better stereognosis. Bar =100 μm.the morphology of the EPCs in cultures. Adherent CD34+
mononuclear cells grew into cerioid colonies after 5-7
days; cobblestone-appearance colonies were observed after
9-11 days; and spindle shaped colonies existed all the time.
On the 4th day after the first passage, which was con-
ducted approximately 2 weeks after the palting, cells grew
more uniformly with the increased spindle shaped cells
and losing of stereognosis.
Adherent unselected mononuclear EPCs grew into
cerioid colonies after 4-6 days, and spindle shaped and
cobblestone-appearance colonies were both observed
during further culturing. The first passage was con-
ducted 8-10 days after the plating and cell morphology
changed with the increased spindle shaped cells and
losing of stereognosis observed on the 1st day after 1st
passage.
Comparing these two isolation methods, selecting
CD34+ mononuclear cells required more time, but the
yield of CD34+ mononuclear cells was lower than unse-
lected cells, and the CD34+ cells grew much slower.Selected CD34+ mononuclear cells and unselected mononuclear cells
g and day 4 after the first passage (P1). Both selected CD34+ and
stone-appearance colonies on day 9, and become more spindle shape
mononuclear cells were cultured in either M 200 or EGM-2 media,
passage (P1). Cells cultured in M 200 proliferated faster than in EGM-2,
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to perform the following experiments.
Effects of culture media on EPCs
The unselected mononuclear EPCs were equally divided
and cultured in two different media: M 200 and EGM-2.
Figure 1B shows the difference in morphology of the
EPCs under two conditions. Both spindle shaped and
cobblestone-appearance cells were observed in M 200
and EGM-2. Cells cultured in M 200 proliferated faster
than in EGM-2, but cells had better stereognosis in
EGM-2.
Effects of serum concentrations on EPCs
The unselected mononuclear EPCs were cultured in
media supplemented with varying concentrations of FBS,
as shown in Figure 2. On the third day, cells in the media
supplemented with FBS grew faster than in media without
FBS supplementation, and this phenomenon was more ob-
vious on the 6th day and last until the 9th day. However,
cells cultured in media containing 7.5% FBS proliferated
better than in media supplemented with 10% FBS.
Effects of culture dishes surface coating on EPCs
The unselected mononuclear EPCs were plated on culture
dishes without coating or coated with 25 μg/ml FN, as
shown in Figure 3. On the 5th day, cells seeded on FN-
coated dishes adhered much better than cells cultured in
dishes without coating, which remained observable untilFigure 2 Effects of serum concentrations on EPCs in cultures. Unselec
supplemented with 7.5% or 10% FBS, observed on day 3, day 6 and
medium without FBS supplementation, but cells in the medium supplemente
with 10% FBS. Bar =100 μm.on the 8th day. Comparing the effects between FBS sup-
plementation and FN coating, we found that the effect of
FN coating was similar with FBS supplementation, but
FBS jeopardizes the multipotential of stem cells [25].
Characterization of cells in cultures
Unselected mononuclear EPCs were cultured on human
FN coated culture dishes and in M 200 or EGM-2 with-
out FBS supplementation. Under this condition, cells
were characterized by surface markers CD34, CD133,
CD31, by FITC-lectin staining, and by the uptake of Dil
AcLDL. FITC-lectin staining and Dil AcLDL uptake are
classical methods for EPCs characterization; binding of
lectin is specific for human endothelial cells, and uptake of
Dil AcLDL is a function associated with endothelial cells
[3,26,27]. There were no differences in the expression of
CD34, CD133, and CD31 between the two different media
(data not shown). The data presented in Figure 4 show
that almost all the cells were bound with FITC-lectin, but
uptake of Dil AcLDL was only observed in a portion of
cell population. Importantly, there was much more
double-positive staining of FITC-lectin and Dil AcLDL in
cells cultured in EGM-2 than those in M 200.
Discussion
There are several reports on isolation and culturing of EPCs
from rodent models [16,28]. However, this is the first report
to describe a procedure to isolate and culture EPCs from
Rhesus monkeys. There were no special requirements forted mononuclear cells were cultured in M 200 or M 200
day 9. Cells in the medium supplemented with FBS grew faster than in
d with 7.5% FBS proliferated better than in the medium supplemented
Figure 3 Effects of culture dish surface coating on EPCs in cultures. Unselected mononuclear cells were seeded in EGM-2 medium without
serum supplementation on FN coated culture dishes. Morphology of EPCs was respectively observed on day 5 and day 8 after culturing. In the
control group, cells were seeded on culture dishes without coating. Cells seeded on FN coated dishes had better adherence than cells seeded on
dishes without coating 5 days after culturing, which remained observable until 8 days after culturing. Bar =100 μm.
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attention needed to be paid. Separation of CD34+
mononuclear cells would be considered an ideal proce-
dure to purify EPCs, but the low yield in addition to
time-consuming would make it less practical for a large
scale collection of these cells. Selection of different types
of media made a remarkable difference in the mainten-
ance of morphology of the isolated EPC. It was also
found that serum supplementation was required, but
high concentrations of sera resulted in more differen-
tiation of EPCs in cultures. Finally, a better result was
obtained if the culture dishes were coated with FN rela-
tive to uncoated culture ware.
There were reports on isolating EPCs using selected
CD34+ or unselected procedures. It appears that the pro-
cedure using selected CD34+ mononuclear cells would
generate relatively purified EPCs. However, studies have
also shown that there was no remarkable advance using
the selected CD34+ cells over the unselected mononuclear
cells in cultures [26,27,29]. In the present study, both pro-
cedures were conducted to make a close comparison. The
results obtained show that there were no apparent diffe-
rences in morphology of EPCs in cultures, but there were
significant differences in time-consuming and yield be-
tween the two procedures. The lower yield of CD34+
mononuclear cells might not reflect an insufficient num-
ber of CD34+ cells in the population, but rather resulted
from less efficient procedure to separate CD34+ cells
using the CD34+ MicroBeads. Considering all of these
drawbacks in the current procedure separating CD34+cells, we recommend that directly using unselected mono-
nuclear cells for the study of EPCs isolated from monkey
models.
The differences between M 200 and EGM-2 media in-
clude compositions and quantity of the same composition.
Although remarkable differences in cell morphology in
cultures were not observed between cells cultured in the
two differenct media, cells cultured in M 200 proliferated
faster than in EGM-2, and cells had better stereognosis in
EGM-2. These alterations would suggest that a selection
of media for culturing EPCs should consider the need for
the eventual application. However, the EGM-2 would a
better medium to maintain undifferentiated shape for a
longer time of culturing.
It is well known that serum is essential for cell growth
and high levels of sera stimulate cell proliferation. It is dif-
ficult to define the optimal concentrations of sera in cul-
tures for maintaining undifferentiated morphology of
EPCs in cultures but sufficiently supporting cell growth.
In this study, we found that serum concentrations at 7.5%
in media would be a better supplementation, and at 10%
promoted differentiation. Therefore, this would provide a
reference in the study of EPCs isolated from monkeys.
FN coated culture dishes provide better adherent sup-
port for cells in cultures. In the present study, it appeared
that FN coating not only provided an adherent support for
EPCs, but also helped cells maintain undifferentiated mor-
phorlogy and promote proliferation. The cell growth pro-
motion observed in the FN coated dishes was comparable
with that observed in the cultures supplemented with
Figure 4 Characterization of cells in cultures by staining cells with FITC-lectin and examing uptake of Dil AcLDL. Unselected
mononuclear EPCs were cultured on FN coated dishes and in M 200 or EGM-2 medium, and characterization was proceeded by uptake of Dil
AcLDL (left, red) and FITC-lectin staining (middle, green). Double positive cells (right, merge) were observed in both M 200 (A-C) and EGM-2
(D-F) on the 19th day after plating, but the number of double positive cells in EGM-2 was much more than in M 200 (G). *, significantly different
(P <0.05). Bar =100 μm.
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for culturing EPCs isolated from monkeys.
Conclusions
Above all, an optimized procedure was developed: un-
selected mononuclear cells were cultured on human FN
coating culture dishes and in EGM-2 without additional
FBS supplementation. Under this condition, spindle shaped
and cobblestone-appearance cells displayed a better
adherence and growth, and were identified to be EPCs.
Methods
Animals
Male Rhesus (Macaca mulatta) monkeys, aged 2-3 years
old and weighed 4.5 to 6.0 kg, were obtained from Chengdu
Ping-An experimental animal breeding and research center,
a Chinese government accredited non-human primate cen-
ter in Sichuan province. The animals were housed in indi-
vidual cages and acclimatized to the laboratory conditionfor a period of at least one month. They received conven-
tional laboratory diet with free access to drinking water,
which was approved by the Laboratory Animal Manage-
ment Committee of Sichuan province. All animal proce-
dures were approved by the Institutional Animal Care
and Use Committee at the Sichuan University West
China Hospital, following the guideline of the US
National Institutes of Health.
Isolation of mononuclear cells
Prior to experimental procedure, all subjects received
an intramuscular injection of 5 mg/kg ketamine and
0.2 mg/kg midazolam to induce sedation. The hairs cov-
ering the iliums or knees at the puncturing sites were
shaved and the exposed skin was sterilized by iodophor
and alcohol in sequence. Bone marrow puncture was
made by using puncture needles and approximately 4-6
ml bone marrow was aspirated from one or both iliums
(or femurs) under strict sterile condition.
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(Gibco, USA), mixed carefully and added on the top of
5-6 ml lymphocyte separation media (density 1.077 g/ml,
TBD, China) at room temperature. After gradient centrifu-
gation at 600 × g for 20 min, the yellow-white plate (mono-
nuclear cells) was collected, washed and cultivated in media
directly or further undergone separation of CD34+ cells.
Separation of CD34+ cells
CD34+ cells were separated using human CD34 MicroBead
Kit (Miltenyi Biotec, Germany) following the instruction
provided. In brief, mononuclear cell suspension was centri-
fuged at 300 × g for 10 min. The cell pellet was resuspended
in 300 μL of autoMACS™ running buffer (Miltenyi Biotec,
Germany), 100 μL of FcR blocking reagent, and 100 μL of
CD34 MicroBeads. After incubation for 30 min in the
refrigerator (2− 4°C), the cells attached to the CD34
MicroBeads were washed with 5 − 10 mL of autoMACS™
running buffer followed by centrifugation at 300 × g for 10
min. The cell pellet was resuspended in 500 μL of auto-
MACS™ running buffer, and applied onto an autoMACS™
running buffer rinsed column on a magnetic separator. The
colume was washed 3 times and removed from the separ-
ator. The cells were flushed out from the colume using 1.0
mL of autoMACS™ running buffer. The collected cells were
washed and cultivated.
Cell culture
Selected CD34+ and unselected mononuclear cells were
cultured in media supplemented with low serum growth
supplement (LSGS, Gibco, USA) containing fetal bovine
serum (FBS), hydrocortisone, human epidermal growth
factor (hEGF), basic fibroblast growth factor (bFGF),
heparin, and antibiotics (penicillin and streptomycin,
Thermo, USA).
Effects of culture media
Cells were equally divided and cultured in two different
media. One portion was cultured in Medium 200 (M 200)
supplemented with low serum growth supplement. An-
other portion was cultured in EGM-2 medium, which is
the endothelial cell basal medium-2 plus EGM-2 MV Sigle-
Quots (Lonza, USA), a supplement kit containing FBS,
hydrocortisone, hFGF-B, VEGF, R3-IGF-1, ascorbic acid,
hEGF, GA-1000, and antibiotics (penicillin and strepto-
mycin, Thermo, USA).
Effects of serum concentrations
Media were supplemented with FBS at different concen-
trations: medium with its own serum (serum concentra-
tion in M 200 was 2%, and in EGM-2 was 5%), and media
with added FBS to the final concentration of 7.5% or 10%
in the medium.Effects of culture dish surface coating
Cells were plated on uncoated culture dishes (BD, USA)
or human fibronectin (FN, Prospec, Israel) coated culture
dishes. The coating was done as follow: 1 ml of 25 μg/ml
human FN was added to the dishes and incubated at room
temperature for 2 hrs, after which the supernatant was re-
moved and dishes were rinsed with PBS buffer.
The first change of media was conducted 3-5 days after
the plating. Afterwards, the media were changed every 3
days, with which non-adherent cells were washed away.
Cells were digested and passaged at 80%-90% confluence
for continuously culturing or characterization.
Characterization of EPCs
The surface marker CD34 (Abcam, UK), CD133 (HuaAn,
China) and CD31 (Abcam, UK) were detected by immun-
cytochemistry. In addition, cells were stained with FITC-
labeled lectin (FITC-lectin, Sigma-Aldrich, USA). The
uptake of Dil-conjugated acetylated low-density lipopro-
tein (Dil AcLDL, Invitrogen, USA) was also measured at
the same time to define functional EPCs.
Immunocytochemistry
Cells were digested and seeded on sterile slides, which
were put in 6-well plates. Before the detection, media were
aspirated and PBS was added to wash cells three times, 5
min each wash. After fixed in cold 4% paraformaldehyde
for 10-15 min and washed with PBS, primary antibodies
diluted with PBS containing 10% serum was added and in-
cubated for 2 hrs at 37°C followed by overnight at 4°C.
The secondary antibody diluted with 10% serum in PBS
was incubated for 1.5 hrs at 37°C. Then DAPI was incu-
bated for 5-10 min at room temperature and slides were
sealed after wash with PBS and examined with laser scan-
ning confocal microscope (LSCM).
FITC-lectin staining and uptake of Dil AcLDL
Cells were seeded on 24-well plates, and undergone star-
vation for 24-48 hrs in media without serum, incubated
with 200 μL 2.4 μg/ml Dil AcLDL 4 hrs at 37°C after
medium removal and wash, and fixed in cold 4% para-
formaldehyde for 10-15 min, followed by incubation in
200 μL 10 μg/ml FITC-lectin for 2 hrs at 37°C, and
examined with LSCM after PBS washing.Statistical analysis
Data were obtained from three separate experiments and
expressed as means ± S.E.M. The significance of differ-
ence between groups was determined by Student T-test.
The level of significance was considered when P < 0.05.Competing interests
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